A multicentre, randomized, double-blind, parallel-group, controlled study, to assess the efficacy and safety of P-3074 cutaneous spray, solution, in the treatment of male pattern baldness.
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 28 Sep 2017
At a glance
- Drugs Finasteride (Primary) ; Finasteride (Primary)
- Indications Alopecia
- Focus Registrational; Therapeutic Use
- Sponsors Polichem
- 22 Sep 2017 Planned End Date changed from 1 Feb 2018 to 1 May 2018.
- 22 Sep 2017 Planned primary completion date changed from 1 Feb 2018 to 9 Mar 2018.
- 22 Sep 2017 Status changed from recruiting to active, no longer recruiting.